Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma.

Name: Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma.
Author: Dietrich, Peter

Neuroblastoma RAS Viral Oncogene Homolog (NRAS) Is a Novel Prognostic Marker and Contributes to Sorafenib Resistance in Hepatocellular Carcinoma. — المؤلف: Dietrich, Peter — Neoplasia (New York, N.Y.) 20190611

المؤلف: Dietrich, Peter
النشر: Neoplasia (New York, N.Y.) 20190611
الوصف: 257-268 p.
الموضوعات: Adult؛ Aged؛ Antineoplastic Agents؛ Apoptosis؛ Biomarkers, Tumor؛ Carcinoma, Hepatocellular؛ Cell Line, Tumor؛ Cell Proliferation